Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation All Wales Medicines Strategy Group (AWMSG). Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy. Penarth: All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG). AWMSG Secretariat Assessment Report Advice No. 1608. 2008 Authors' conclusions Stiripentol (Diacomit®) is not recommended for use within NHS Wales for the treatment of severe myoclonic epilepsy in infancy Indexing Status Subject indexing assigned by CRD MeSH Adolescent; Anticonvulsants; Benzodiazepines; Child; Dioxolanes; Epilepsies, Myoclonic; Infants; Valproic Acid Language Published English Country of organisation Wales English summary An English language summary is available. Address for correspondence All Wales Therapeutics and Toxicology Centre, Academic Centre, University Hospital Llandough, Penlan Road,
Penarth, Vale of Glamorgan CF64 2XX
Email: AWTTC@wales.nhs.uk AccessionNumber 32012000427 Date abstract record published 08/08/2012 |